The global cannabidiol consumer health market size was valued at USD 28.83 billion in 2025 and is projected to grow from USD 33.31 billion in 2026 to USD 105.87 billion by 2034, registering a CAGR of 15.55% during the forecast period from 2026 to 2034. North America dominated the cannabidiol consumer health market with a market share of 51.34% in 2025.
The cannabidiol (CBD) consumer health market is evolving rapidly, driven by growing demand for plant-based wellness solutions targeting stress, sleep disorders, and chronic pain management. Increasing consumer preference for non-prescription, natural alternatives is accelerating adoption across oils, gummies, beverages, and topical applications. Brands such as Charlotte’s Web Holdings, Inc. and cbdMD, Inc. have expanded portfolios into functional products like sleep-support gummies and calming tinctures, reflecting a shift toward condition-specific offerings. Retail expansion into pharmacies and mainstream outlets, along with direct-to-consumer models, is improving accessibility. Companies like Canopy Growth Corporation are leveraging beverage innovations and strategic partnerships to maintain CBD consumption. Regulatory clarity in key regions and increased product standardization are further strengthening consumer trust, positioning CBD as an emerging segment within preventive and lifestyle healthcare.
Download a Free Sample To learn more about this report.
The nutraceuticals segment is projected to grow at a CAGR of 8.94% during the forecast period, due to rising consumer preference for preventive healthcare supplements integrated with daily diets, increasing demand for functional ingredients targeting immunity, sleep, and stress management, and strong expansion of clean-label and plant-based formulations supported by retail pharmacy and e-commerce wellness channels.
The medical OTC products segment is expected to grow at a CAGR of 15.96% during the forecast period, driven by pharmacist-guided self-medication in retail pharmacies, AI-based symptom-to-product recommendation systems in digital pharmacy platforms, and growing consumer preference for instant treatment of minor conditions like pain, acidity, and allergies, reducing reliance on prescription consultations and accelerating direct OTC purchasing behavior.
Request Customizationto receive a tailored report.
The drug stores & retail pharmacies segment dominated the Cannabidiol (CBD) consumer health market with a revenue share of 41.32% in 2025. This dominance is attributed to pharmacist-assisted CBD product guidance ensuring safer usage, strong in-store trust that increases consumer confidence in regulated environments, and wide product accessibility through established pharmacy networks that support repeat purchases, standardized quality assurance, and easier compliance with evolving regulatory retail frameworks across regions.
The online pharmacies segment is projected to grow at a CAGR of 16.47% during the forecast period due to e-prescription integration enabling direct digital ordering, discreet doorstep delivery, improving privacy for sensitive CBD purchases, and AI-driven pharmacy platforms enhancing personalized product recommendations and availability, increasing convenience, conversion rates, and repeat purchases across regulated and emerging consumer health markets.
Speak to an Analystto discuss market opportunities.
The North America cannabidiol (CBD) consumer health market, which captured 51.34% of global revenue in 2025, is propelled by state-level retail legalization frameworks that allow CBD products to be widely sold in pharmacies, wellness chains, and convenience stores, creating strong mainstream accessibility. Strong presence of vertically integrated hemp cultivation and extraction infrastructure in the US, which ensures a consistent raw material supply and faster product innovation. Strong wellness retail marketing and early consumer awareness from established cannabis legalization have significantly normalized CBD use across daily health routines, accelerating adoption across stress, sleep, and pain management.
The US cannabidiol (CBD) consumer health market is growing due to the expansion of state-regulated hemp retail licensing, allowing CBD to be sold through dispensaries, wellness clinics, and specialty health stores with structured compliance frameworks. Additionally, strong venture capital investment in US-based CBD startups is accelerating product innovation in nano-emulsions, beverages, and topical therapies, strengthening market competitiveness and commercialization speed across consumer wellness categories.
The Canada cannabidiol (CBD) consumer health market is supported by the strong presence of Health Canada mandated product licensing and strict cannabinoid content testing requirements, which increase consumer trust in product safety and labeling accuracy. The integration of CBD products into regulated pharmacy and dispensary channels allows medically guided retail access under controlled frameworks. Growing collaboration between licensed cannabis producers and Canadian wellness and nutraceutical companies is driving development of standardized CBD-infused health supplements tailored for stress, sleep support, and recovery, strengthening mainstream acceptance and structured product innovation.
Unlock Regional Insightsto access country-level data, & regional trends.
The Asia Pacific cannabidiol (CBD) consumer health market is expected to register the fastest growth with a CAGR of 17.49% during the forecast period due to the integration of CBD into rapidly expanding beauty and personal care manufacturing hubs in countries like South Korea and Japan, where cosmetic innovation ecosystems actively test functional actives in skincare formulations. The rising use of CBD in export-oriented hemp cultivation economies, where countries like China and Australia are leveraging large-scale hemp farming for global supply chains. Increasing acceptance of CBD within alternative wellness frameworks linked to urban stress management in high-density cities like Tokyo, Seoul, and Singapore is accelerating premium product demand across lifestyle and nutraceutical categories.
The China cannabidiol (CBD) consumer health market is expanding due to the country’s dominant position in global hemp cultivation and vertically integrated industrial supply chains, which ensure large-scale availability of low-cost CBD raw materials for export-oriented production. Another key factor is the strong government-controlled licensing system that restricts CBD use mainly to cosmetics, creating a highly concentrated and regulated premium skincare segment rather than fragmented consumer consumption.
Thailand’s cannabidiol (CBD) consumer health market growth is supported by the country’s progressive medical cannabis framework that allows controlled use of CBD in traditional Thai medicine hospitals and licensed wellness clinics, creating a structured clinical adoption pathway. Thailand’s strong wellness tourism industry, where CBD-infused spa therapies, relaxation oils, and massage treatments are increasingly integrated into high-end hospitality offerings. The presence of a rapidly expanding domestic cannabis cultivation ecosystem under government-supervised pilot programs further supports market growth.
The cannabidiol (CBD) consumer health market is highly fragmented, with a mix of established cannabis companies, wellness brands, and ingredient suppliers competing across oils, edibles, topicals, and functional wellness products. Large players such as Charlotte’s Web Holdings, Inc., Canopy Growth Corporation, and CV Sciences, Inc. dominate through vertically integrated operations, strong distribution networks, and brand recognition. Mid-sized firms compete through product specialization in sleep, stress, and pain relief segments, while smaller startups focus on niche innovation like nano-CBD and functional beverages. However, regulatory uncertainty and limited clinical standardization prevent full consolidation, keeping competition dynamic and innovation driven.
Customize This Report to Match Your Strategic Objectives
Preeti Bhagat is a research professional with around more than three years of experience in the market research industry, specializing in market analysis, secondary research, market estimation, forecasting, and competitive intelligence. She has developed expertise across industries including Packaging and Consumer Goods, supporting businesses with data-driven insights into market dynamics, industry trends, competitive landscapes, and growth opportunities.
Her experience includes conducting comprehensive secondary research, market sizing, demand analysis, company profiling, competitive benchmarking, and trend assessment. She has hands-on experience with structured research methodologies, including top-down and bottom-up approaches, to assess market potential, growth opportunities, and future market performance.
We are featured on:
sales@straitsresearch.com